China Releases 2025 Catalog Encouraging Foreign Investment in Medical Devices

New EditionCatalogue for Encouraging Foreign Investment IndustriesPublish

Involving these medical devices

Today (12Month24Day), the National Development and Reform Commission, Ministry of Commerce issuedCatalogue of Industries Encouraging Foreign Investment(2025Year Edition)》。

The release of the revised new version of the "Encouragement Catalog" is an important measure to attract and utilize foreign investment with greater intensity. The new version of the "Encouragement Catalog"2022Net increase compared to the year edition205Articles, Amendments303Article，There are mainly three aspects of changes.

1. Encourage and guide foreign businesses to invest in advanced manufacturing industries. 2. Encourage and guide foreign businesses to invest in modern service industries. 3. Encourage and guide foreign businesses to invest in the central and western regions, northeastern regions, and Hainan Province of China.

Catalog includes the Catalog of Industries Encouraged for Foreign Investment in China、Catalogue of Advantageous Industries for Foreign Investment in Central and Western Regions，WillSelf2026Year2Month1Effective from the date, which involves a large number of medical device-related industries.

According to the梳理by Saibailun Equipment,《Catalogue of Industries Encouraged for Foreign Investment in China》Artificial blood vessels have been newly added in China,Atrial Fibrillation Ablation Devices and Consumables、Prostate Ablation Devices and ConsumablesAnd other medical device content.

The relevant content of medical devices involved includes:

In addition, "China's Encouraged Foreign Investment Industries Catalog》Also includes some medical services andHealth、Social WorkRelated content,Among which, newly addedProduction and Manufacturing of Pet Diagnostic and Treatment Equipment，Pet Hospital, Pet Grooming Services，Pet Diagnosis, Treatment Technology R&D and Product ManufacturingEtc.

Medical Services andHealth、Social WorkThe relevant content includes:

Still included in the new edition of the catalog"Medical institutions", however, compared to before, the window in this field has been further relaxed.

Last year, the National Health Commission and other4Department Release "Notice on Printing and Distributing the Pilot Work Plan for Expanding Opening-up in the Wholly Foreign-Owned Hospital Sector》，Promote the orderly expansion of openness in the medical field, allowing wholly foreign-owned hospitals to be established in Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and across Hainan Island.. Just this month,Hainan's First Wholly Foreign-Owned Hospital“Boao Fulong Hospital”In Haikou, the plaque was unveiled.，Tianjin, Jiangsu, Guangzhou, Chongqing, Yunnan and other places have also advanced construction and deployment.

《Catalogue of Advantageous Industries for Foreign Investment in Central and Western Regions》The medical and medical device-related content involved includes:

Overall, Sichuan currently encourages the most foreign investment in advantageous projects. In recent years,Medtronic、GEHealthcare, Fresenius,CochlearA group of multinational medical device companies, such as Medtronic, are increasing their investment and layout in Sichuan.Cochlear, the leading company in the cochlear implant industryThe First Manufacturing Base in ChinaSettled in Chengdu, this year3Monthly mass production achieved。GEThe Precision Medical Industry Base in China is located in Chengdu.

"Made in China" Standards Re-defined

The Foreign Investment Environment Continues to Improve

Since the beginning of this year, the state level has been encouraging and supporting foreign investment, and the environment for foreign investment has further improved.

12Month24On the [date], the Ministry of Finance issued "Regarding the Implementation of<Notice of the General Office of the State Council on Implementing National Product Standards and Relevant Policies in Government Procurement>Opinions》（Hereinafter referred to as the "Opinion")。Among them, especially for medical devicesNational Product StandardsAn explanation was provided.

The Opinion points out that the accurate definition of products manufactured within China should be provided. The Notice clarifies that domestically produced products should be manufactured within China, meaning the transformation from raw materials and components to finished products occurs within the customs territory of the People’s Republic of China. In specific cases, products manufactured in domestic bonded areas, comprehensive bonded areas, and other special customs supervision zones are considered as products produced within China.For medical device products, those that have obtained the 'Zhun' character medical device registration certificate granted by the drug supervision and administration department are products produced within China.。

The Opinion also requires that all levels of budget units embed domestic product standards and relevant policy requirements into each环节 of government procurement, including procurement needs, procurement documents, procurement contracts, and performance acceptance., ensure that2026Year1Month1Implement policy requirements in government procurement starting from the date. 

At that time,Subsidiaries of multinational medical device enterprises「Domestically Produced Products」, and will enjoy the same treatment in government procurement.`, competing on the same stage as local brands.`

This Year2Released in ...2025The annual plan for stabilizing foreign investment clearly states,Research and improve the opening-up policies in the pharmaceuticals sector to facilitate the faster market entry of innovative drugs.Optimize the volume-based drug procurement and further improve the predictability of medical device product procurement.。

In recent years, the market influence of centralized procurement in the medical device field has been expanding, extending from various types of medical consumables to medical equipment, with terminal product prices significantly reduced. Both local and foreign enterprises face considerable industry challenges. However, the optimization of the entire centralized procurement chain sends a positive signal. The increased predictability of device procurement will also enable foreign medical device companies to deploy their strategies in China more effectively.

END